The Technology Transfer and Innovation Unit “ARCHIMEDES” of the National and Kapodistrian University of Athens announces the establishment of a new spin-off company under the name “Finite Absorption Time (F.A.T.) Laboratories”, an innovative enterprise offering specialized pharmacokinetic services based on the pioneering F.A.T. methodology. The founding team of F.A.T. Laboratories includes Emeritus Professor Panos Macheras from the Department of Pharmacy, as well as members of NKUA from the Departments of Pharmacy, Medicine, and Chemistry.
F.A.T. Laboratories aims to play a significant role in accelerating and reducing the cost of drug and generic development. Through advanced software tools and scientifically validated methods, the company will provide pharmacokinetic and pharmacodynamic analysis solutions designed to support drugs companies, generic manufacturers, CROs, and biotechnology start-ups.
The core services of F.A.T. Laboratories (https://fat-laboratories.com/) include:
- Development of drugs, generics and supergenerics based on F.A.T. principles
- Pharmacokinetic and pharmacodynamic studies
- Bioequivalence studies, using both classical and F.A.T. methodology
- Analysis of classical and population Phase II and III studies using F.A.T. software
- Consulting services for drug and generic development
This new spin-off is founded on software technology that enables prediction and optimization of drug absorption, offering a reliable and scientifically accepted tool recognized by regulatory authorities and suitable for supporting Level A IVIVC.
The F.A.T. Laboratories team is composed of experienced scientists specializing in drug development, quality assurance, and informatics, providing a comprehensive and innovative approach to research and development in the pharmaceutical sector.
We wish every success in this new venture!
